Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003148663 | SCV003836622 | benign | Familial adenomatous polyposis 1 | 2023-02-18 | reviewed by expert panel | curation | The c.423-4del variant in APC is an intronic variant which results in the deletion of adenine at position -4 of intron 4. The highest allele frequency is 5.48% in gnomAD v3.1.2, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold for BA1 (0.1%). RNA assays showed no splicing mutation, indicating that this variant does not impact protein function (BS3_Supporting; PMID22447671). Finally, the results from more than or equal to 2 in silico splicing predictors support that this variant does not affect splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1, BS3_Supporting, BP4. (VCEP specifications version 1; date of approval: 12/12/2022). |
Gene |
RCV000159526 | SCV000209483 | benign | Hereditary cancer-predisposing syndrome | 2014-03-27 | criteria provided, single submitter | clinical testing | The variant is found in COLO-HEREDIC panel(s). |
Ambry Genetics | RCV000159526 | SCV000212933 | benign | Hereditary cancer-predisposing syndrome | 2020-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000159526 | SCV000686966 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-13 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000159526 | SCV000686968 | benign | Hereditary cancer-predisposing syndrome | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003148663 | SCV001729424 | benign | Familial adenomatous polyposis 1 | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001353891 | SCV002011090 | benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000159526 | SCV002531960 | benign | Hereditary cancer-predisposing syndrome | 2020-01-30 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000202236 | SCV002550560 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498791 | SCV002808185 | likely benign | Desmoid disease, hereditary; Familial adenomatous polyposis 1; Hepatocellular carcinoma; Gastric cancer; Colorectal cancer; Gastric adenocarcinoma and proximal polyposis of the stomach | 2022-01-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003148663 | SCV004931034 | benign | Familial adenomatous polyposis 1 | 2024-02-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. |
Mayo Clinic Laboratories, |
RCV000202236 | SCV000256994 | likely benign | not specified | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV001353891 | SCV000591029 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001353891 | SCV001743864 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001353891 | SCV001806851 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000202236 | SCV001925185 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000202236 | SCV002034223 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000202236 | SCV002036494 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003975227 | SCV004797387 | benign | APC-related disorder | 2023-11-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |